This course examines the transition of biomedical discoveries into clinical and commercial applications, focusing on protein-based therapeutics, gene therapies, and biologics. Students evaluate the development, manufacturing, and regulatory approval processes for monoclonal antibodies, recombinant proteins, RNA-based drugs, and gene therapies. The course also investigates clinical trial design, biopharmaceutical industry strategies, and personalized medicine approaches. Case studies on therapeutic breakthroughs in cancer, infectious diseases, and rare genetic disorders are highlighted.
This course examines the transition of biomedical discoveries into clinical and commercial applications, focusing on protein-based therapeutics, gene therapies, and biologics. Students evaluate the development, manufacturing, and regulatory approval processes for monoclonal antibodies, recombinant proteins, RNA-based drugs, and gene therapies. The course also investigates clinical trial design, biopharmaceutical industry strategies, and personalized medicine approaches. Case studies on therapeutic breakthroughs in cancer, infectious diseases, and rare genetic disorders are highlighted.
